GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Chronic Nausea & Vomiting
Functional GI

Chronic Nausea & Vomiting

Rome IV — chronic nausea and vomiting syndrome

Either this or the nausea criterion satisfies requirement 1 — both are not needed.

Rumination is the exclusion most often missed, because patients describe effortless regurgitation as vomiting. Ask whether it is preceded by retching — in rumination it is not.

Criterion 1 is an OR — bothersome nausea at least 1 day a week, or at least one vomiting episode a week, or both. Self-induced vomiting, eating disorders, regurgitation and rumination all have to be excluded first.

When to use
Use it in a patient with persistent day-to-day nausea, with or without vomiting, once the routine work-up is negative. It is the diagnosis for the large group of patients who have chronic nausea as their dominant symptom and who fall through the gaps — too continuous for cyclic vomiting syndrome, insufficiently meal-related for functional dyspepsia, and without the delayed emptying that would give them a gastroparesis label. Before applying it, exclude rumination specifically, since patients describe effortless regurgitation as vomiting and that is the exclusion most often missed. It does not apply where the vomiting is episodic with well periods in between.
Why use it
Because chronic nausea is disabling, common, and badly served by the alternatives. Patients typically accumulate a gastroparesis label if their emptying study happens to be borderline, a functional dyspepsia label if the epigastric symptoms predominate, or no label at all — and the absence of a name means the assessment keeps restarting. Rome IV's contribution is to define the disorder on nausea in its own right rather than as an appendage to something else, and to force the exclusions that actually change management: self-induced vomiting, eating disorders and rumination all have specific treatments and are all missed when a patient's presenting word is 'vomiting'. Naming the syndrome also redirects treatment from anti-emetics, which rarely control chronic nausea, toward neuromodulation.
Formula, evidence and interpretation

About the Rome IV Criteria for Chronic Nausea and Vomiting Syndrome

Continuous rather than episodic — that is what separates this from cyclic vomiting syndrome, and severity has nothing to do with it. Rome IV requires bothersome nausea occurring at least one day per week *and/or* one or more vomiting episodes per week; exclusion of self-induced vomiting, eating disorders, regurgitation and rumination; and no evidence of organic, systemic or metabolic disease on routine investigation including upper endoscopy. Criteria are fulfilled over three months with onset at least six months ago. Note the OR in the first criterion: nausea alone satisfies it, and so does vomiting alone.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Chronic nausea and vomiting syndrome = ALL of: bothersome nausea at least 1 day per week OR 1 or more vomiting episodes per week AND no self-induced vomiting, eating disorder or rumination AND no other explanation after appropriate evaluation AND criteria fulfilled for the last 3 months, onset at least 6 months ago
OR, not AND
The entry criterion is satisfied by nausea alone or by vomiting alone. Rome IV merged chronic idiopathic nausea and functional vomiting to make this possible.
Bothersome
Severe enough to impact usual activities, which is what separates the criterion from ordinary intermittent nausea.
Exclusions
Self-induced vomiting, an eating disorder and rumination must all be excluded — the first two are not gastroenterological questions.
  • The entry criterion is an OR, so nausea alone or vomiting alone qualifies — Rome IV merged two former categories to make this possible.
  • Bothersome means severe enough to impact usual activities.

Interpreting the result

A patient meeting these criteria has a chronic disorder of nausea perception, and the treatment reflects that. Anti-emetics alone rarely achieve control, and low-dose neuromodulators are the mainstay — explained, as elsewhere, in terms of nerve sensitivity rather than mood. Before settling on the diagnosis, work through the causes that routine investigation will not surface: medications, particularly opioids and GLP-1 receptor agonists; cannabis, which causes chronic nausea as well as the hyperemetic pattern; diabetes and its control; and pregnancy where relevant. The relationship with gastroparesis deserves honesty — the two overlap heavily, gastric emptying correlates poorly with symptoms in both directions, and the label a patient ends up with often depends on whether an emptying study happened to be done rather than on a real difference. Vomiting without nausea is the one pattern that should prompt a different line of thought altogether, since it raises the possibility of central nervous system disease and does not fit a functional diagnosis comfortably.

ScoreBandWhat it meansAction
All criteria metChronic nausea and vomiting syndromeContinuous or near-continuous nausea and/or weekly vomiting, with the specific exclusions satisfied and routine investigation negativeNeuromodulators rather than anti-emetics alone; review medication, cannabis and diabetes control
Rumination not excludedCriteria not met — check for ruminationEffortless regurgitation without retching is a different disorder with a different treatmentAsk whether retching precedes the event; if not, assess for rumination syndrome
Episodic pattern with well periodsCriteria not met — cyclic patternDiscrete stereotypical episodes point to cyclic vomiting syndrome rather than a continuous disorderAssess for cyclic vomiting syndrome, and ask about cannabis

What the Chronic Nausea & Vomiting needs (4 inputs)

Timing
Criteria fulfilled for the last three months with symptom onset at least six months before diagnosis.
Bothersome nausea at least 1 day per week AND/OR one or more vomiting episodes per week
An OR, not an AND. Either limb satisfies the criterion on its own — a patient with chronic nausea and no vomiting qualifies, and so does a patient with weekly vomiting and little nausea. Bothersome means severe enough to impact usual activities.
Self-induced vomiting, eating disorders, regurgitation and rumination all excluded
Four separate exclusions, and rumination is the one most often overlooked because patients describe effortless regurgitation as vomiting. The distinguishing question is whether retching precedes it — in rumination it does not.
No evidence of organic, systemic or metabolic disease likely to explain the symptoms on routine investigation, including upper endoscopy
Upper endoscopy is named explicitly. Medication review, diabetes control, pregnancy where relevant, and cannabis use all belong in this assessment and are all common causes of chronic nausea that routine bloods will not reveal.

What it returns

Criteria met or not met
All four requirements including the timing rule must hold, with criterion 1 satisfied by either limb.
Which criteria remain outstanding
Named explicitly, since an unmet exclusion points to a specific alternative diagnosis rather than to an incomplete work-up.

How it is calculated

Rome IV separated the nausea and vomiting disorders by temporal pattern rather than by severity or by presumed mechanism. Chronic nausea and vomiting syndrome occupies the continuous end: symptoms present most weeks, without the discrete stereotypical episodes and well intervals that define cyclic vomiting syndrome. The decision to allow either nausea or vomiting to satisfy the entry criterion reflects clinical reality — chronic nausea without vomiting is common and disabling, and previous frameworks that required vomiting excluded a large group of patients who plainly had a disorder. The exclusions are unusually specific for a Rome definition because the conditions listed are all mistakable for vomiting on a patient's own account, and each has a different treatment. The mechanistic account involves visceral hypersensitivity and altered central processing of nausea, which is why neuromodulators outperform anti-emetics here.

Facts & figures

Sorting the Rome IV nausea and vomiting disorders
PatternDisorderKey discriminator
Continuous or near-continuousChronic nausea and vomiting syndromeNausea ≥ 1 day/week and/or vomiting ≥ 1 episode/week
Discrete stereotypical episodes with well periodsCyclic vomiting syndrome≥ 3 episodes in a year and 2 in 6 months, no vomiting between
Discrete episodes plus heavy cannabis useCannabinoid hyperemesis syndromeResolves on sustained cessation
Effortless regurgitation of food, no retchingRumination syndromeNot preceded by retching; recognisable food within minutes of eating

The four are separated by temporal pattern and by mechanism rather than by severity. All can be severe, and severity is not a discriminator.

Causes routine investigation will not surface
CauseNote
MedicationOpioids and GLP-1 receptor agonists are the common current culprits; review the whole list
CannabisCauses chronic nausea as well as the hyperemetic pattern; ask about frequency and duration
DiabetesBoth the disease and its control; also raises the gastroparesis question
PregnancyWhere relevant, and easily assumed away
Eating disorderAn explicit Rome IV exclusion, and one that requires a direct and careful enquiry
RuminationThe exclusion most often missed, because patients call it vomiting

Rome IV requires organic, systemic and metabolic disease to be excluded on routine investigation, but several of the commonest explanations for chronic nausea are historical rather than investigational.

Evidence

Derivation — Rome Foundation, gastroduodenal disorders committee

2016

Consensus criteria from the Rome IV gastroduodenal disorders committee, published in Gastroenterology in 2016.

Consensus-derived. Rome IV merged what had been separate categories of chronic idiopathic nausea and functional vomiting into a single syndrome, and set the entry criterion as an OR so that nausea alone or vomiting alone would qualify.

Epidemiology of Rome IV functional nausea and vomiting disorders

2018

Population study of adults meeting Rome IV criteria for the functional nausea and vomiting disorders, examining prevalence, clinical characteristics and associations.

Characterised the population meeting these criteria and its overlap with other disorders of gut-brain interaction, supporting the separation of the continuous and cyclic patterns.

Boundary with gastroparesis

2016

Published comparisons of patients with chronic unexplained nausea and vomiting against those with delayed gastric emptying.

Found substantial overlap, with emptying rate correlating poorly with symptom severity in both directions — supporting the position that the two labels describe overlapping populations rather than distinct diseases.

How it compares

Chronic Nausea & Vomiting vs Cyclic vomiting syndrome

Separated by pattern, not severity — this disorder is continuous, cyclic vomiting syndrome is episodic with genuinely well periods between attacks.

Cyclic vomiting syndrome requires the absence of vomiting between episodes, with discrete stereotypical attacks meeting specific counts. Chronic nausea and vomiting syndrome has no episodic structure: symptoms are present most weeks. Both can be severe, and severity does not distinguish them. The distinction matters because cyclic vomiting syndrome is managed in two phases with abortive and prophylactic therapy, often migraine-directed, while a continuous disorder needs continuous treatment. Milder background symptoms between cyclic episodes are permitted, which does blur the boundary in some patients.

Open the Cyclic vomiting syndrome calculator →

Chronic Nausea & Vomiting vs Gastroparesis

Overlapping populations rather than distinct diseases — the label often depends on whether an emptying study was done, and emptying correlates poorly with symptoms.

Gastroparesis requires delayed gastric emptying with compatible symptoms; chronic nausea and vomiting syndrome does not test emptying at all. In practice a substantial proportion of patients meeting these Rome IV criteria have delayed emptying if tested, patients labelled gastroparetic frequently normalise on repeat testing, and emptying rate predicts symptom severity poorly in both directions. The honest position is that the two describe overlapping groups. A gastric emptying study is worth doing where the result would change management — before considering gastroparesis-specific therapies — but neither a normal nor an abnormal result settles the clinical problem.

Chronic Nausea & Vomiting vs Rumination syndrome

An explicit Rome IV exclusion, and the one most often missed — patients call effortless regurgitation vomiting, and the two have completely different treatments.

Rumination must be excluded before this diagnosis can be made, and the separating question takes seconds: does retching precede the event. In rumination it does not, the material is recognisable and often non-acidic food, and it appears within minutes of eating. Missing this sends a patient with a behavioural disorder that responds to diaphragmatic breathing down a pathway of anti-emetics, neuromodulators and gastric emptying studies. The direction of error is almost always the same, because 'vomiting' is the word patients reach for.

Open the Rumination syndrome calculator →Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome. Clin Gastroenterol Hepatol. 2018;16(10):1549-1555.

Pearls & pitfalls

  • Criterion 1 is an OR. Nausea at least one day a week satisfies it without any vomiting at all, and requiring both misapplies the criteria and excludes the largest group of patients.
  • Rumination is the exclusion most often missed. Ask whether retching precedes the event — in rumination it does not, and the material is recognisable food within minutes of eating.
  • Ask about eating disorders and self-induced vomiting directly and without judgement. Both are explicit Rome IV exclusions and neither is volunteered.
  • Review the medication list properly. Opioids and GLP-1 receptor agonists are common current causes of chronic nausea and are frequently overlooked because they were started for something else.
  • Ask about cannabis. It causes chronic nausea as well as the episodic hyperemetic pattern, and patients rarely connect it because it relieves nausea acutely.
  • Vomiting without nausea is atypical and should raise the possibility of central nervous system disease rather than being absorbed into a functional label.
  • The boundary with gastroparesis is blurred. A gastric emptying study is worth doing where the result would change management, but a normal one does not invalidate the symptoms and an abnormal one does not fully explain them.
  • Anti-emetics alone rarely control chronic nausea. Escalating through them without adding a neuromodulator is a common pattern of treatment failure.
  • Episodic vomiting with well periods is a different disorder — that is cyclic vomiting syndrome, and the management differs substantially.

Critical actions

  • Establish the temporal pattern explicitly — continuous versus episodic — since that is what separates this from cyclic vomiting syndrome.
  • Ask whether the events are preceded by retching, to exclude rumination.
  • Enquire directly about self-induced vomiting and eating disorders.
  • Review all medications, with particular attention to opioids and GLP-1 receptor agonists.
  • Take a cannabis history including frequency and duration.
  • Check diabetes status and control; consider pregnancy where relevant.
  • Perform upper endoscopy and appropriate routine investigation to exclude organic, systemic and metabolic disease.
  • Start a low-dose neuromodulator rather than escalating anti-emetics indefinitely, and explain it in terms of nerve sensitivity.
  • Consider a gastric emptying study where the answer would change management, while being clear about the limits of what it settles.

Why this score exists

Rome IV collapsed two earlier categories — chronic idiopathic nausea and functional vomiting — into one syndrome, on the grounds that separating them served no clinical purpose. Patients moved between the categories over time, the treatments were the same, and requiring vomiting for one of them excluded a large group whose dominant and most disabling symptom was nausea alone. The decision to make the entry criterion an OR follows directly from that. The committee also chose to be unusually explicit about exclusions, naming self-induced vomiting, eating disorders, regurgitation and rumination individually rather than relying on a general instruction to exclude other causes. That specificity reflects a practical observation: all four are described by patients as vomiting, all four have distinct treatments, and all four are routinely missed when the clinician accepts the patient's word for what is happening.

About the creator

  • Vincenzo Stanghellini

    First author, Rome IV gastroduodenal disorders committee

    Chaired the committee that produced the Rome IV gastroduodenal criteria.

  • William L. Hasler

    Co-author; nausea and vomiting disorders

    Co-authored the nausea and vomiting disorders section, including the merger of chronic idiopathic nausea and functional vomiting.

Limitations

  • The boundary with gastroparesis is not clean, and which label a patient receives frequently depends on whether an emptying study was performed rather than on a real difference.
  • Relies on excluding four specific conditions, at least two of which — eating disorders and self-induced vomiting — depend on disclosure the patient may not give.
  • The allowance for milder interepisodic symptoms in cyclic vomiting syndrome blurs the boundary between the continuous and episodic disorders.
  • A consensus construct — the decision to merge chronic idiopathic nausea with functional vomiting was a judgement about clinical utility, not a finding from a cohort.
  • 'Routine investigation' is not specified beyond upper endoscopy, so the depth of the organic work-up varies widely between clinicians.
  • Does not address the substantial psychological comorbidity accompanying chronic nausea, which frequently needs treating alongside.
  • Says nothing about severity, and patients range from mildly troubled to unable to maintain nutrition.
  • Treatment evidence specific to this syndrome is thinner than for functional dyspepsia, and much of it is extrapolated from other disorders of gut-brain interaction.

If you are the patient

Chronic nausea and vomiting syndrome means feeling sick, being sick, or both, on most weeks over months — without the tests showing a physical cause. The important distinction from some other conditions is that it is ongoing rather than coming in separate attacks with well periods in between. You do not have to be vomiting to have this: persistent nausea on its own, if it is bad enough to interfere with your usual activities at least one day a week, is enough. Before settling on this diagnosis, your doctor should check several things that ordinary blood tests will not show — the medicines you take, since some common ones including strong painkillers and certain diabetes and weight-loss injections cause nausea; cannabis use, which causes ongoing nausea as well as a separate pattern of severe attacks; and diabetes control. They should also ask whether food comes back up without any retching beforehand, because that is a different and very treatable condition called rumination which is frequently mistaken for vomiting. As for treatment, ordinary anti-sickness tablets on their own often do not control chronic nausea well. The medicines that tend to work better are low doses of drugs that calm nerve signalling between the gut and the brain — these are often also used as antidepressants, but here they are used at much smaller doses and for their effect on nerves rather than mood.

Frequently asked questions

What are the Rome IV criteria for chronic nausea and vomiting syndrome?#

Bothersome nausea occurring at least one day per week and/or one or more vomiting episodes per week; exclusion of self-induced vomiting, eating disorders, regurgitation and rumination; and no evidence of organic, systemic or metabolic disease on routine investigation including upper endoscopy. Criteria must be fulfilled for three months with onset at least six months earlier.

Do you need vomiting to meet the criteria?#

No. The first criterion is an OR — bothersome nausea at least one day a week satisfies it on its own, and so does weekly vomiting on its own. Rome IV deliberately merged the earlier categories of chronic idiopathic nausea and functional vomiting partly because requiring vomiting excluded a large group whose dominant and most disabling symptom was nausea.

How is this different from cyclic vomiting syndrome?#

Pattern, not severity. Chronic nausea and vomiting syndrome is continuous or near-continuous; cyclic vomiting syndrome consists of discrete stereotypical attacks with well periods in between and requires the absence of vomiting between episodes. Both can be severe. The distinction matters because cyclic vomiting syndrome is managed with two-phase abortive and prophylactic therapy that does not map onto a continuous disorder.

Why must rumination be excluded first?#

Because patients describe effortless regurgitation as vomiting, and rumination has a completely different treatment — diaphragmatic breathing rather than neuromodulators or anti-emetics. The separating question is whether retching precedes the event: in rumination it does not, and the material is recognisable food brought up within minutes of eating. It is the exclusion most often missed.

What is the difference between this and gastroparesis?#

Gastroparesis requires delayed gastric emptying on formal testing; this syndrome does not test emptying. In practice the two overlap heavily — many patients meeting these criteria have delayed emptying if tested, patients labelled gastroparetic often normalise on repeat testing, and emptying rate predicts symptom severity poorly. Which label a patient carries frequently depends on whether a study was done rather than on a genuine difference.

What causes chronic nausea that tests might miss?#

Medication is the commonest — opioids and GLP-1 receptor agonists particularly, and both are often overlooked because they were started for something else. Cannabis causes chronic nausea as well as the episodic hyperemetic pattern, and patients rarely suspect it because it relieves nausea acutely. Diabetes and its control, pregnancy where relevant, and eating disorders all belong in the assessment and none is revealed by routine bloods.

How is chronic nausea and vomiting syndrome treated?#

Low-dose neuromodulators are the mainstay, explained in terms of nerve sensitivity rather than mood. Anti-emetics alone rarely achieve control of chronic nausea, and escalating through them without adding a neuromodulator is a common pattern of treatment failure. Addressing contributory medication, cannabis use and diabetes control frequently does more than any prescription.

Is vomiting without nausea part of this syndrome?#

It is atypical and should prompt caution. Vomiting in the absence of nausea raises the possibility of central nervous system disease, and Rome IV notes this pattern as one that warrants consideration of an organic cause rather than a functional diagnosis. It does not fit comfortably within this syndrome and should not be absorbed into it without thought.

Related calculators

  • Cyclic Vomiting Syndrome — Rome IV — stereotypical episodic vomiting
  • Cannabinoid Hyperemesis — Rome IV — CVS pattern relieved by cannabis cessation
  • Rumination Syndrome — Rome IV — effortless regurgitation without retching
  • Functional Dyspepsia — Rome IV — with PDS and EPS subtyping
  • Belching Disorders — Rome IV — supragastric vs gastric belching

References

Original / primary reference

  1. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380-1392 (Rome IV).

Related disorders and exclusions

  1. Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome. Clin Gastroenterol Hepatol. 2018;16(10):1549-1555.
  2. Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2019;31 Suppl 2:e13604.

Last updated July 31, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.